A new market research report by Transparency Market Research, titled “Atopic Dermatitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” provides a comprehensive analysis of the global atopic dermatitis treatment market. The study includes a market overview, product segmentation, market drivers and restraints, opportunities and challenges, market trends, geographical segmentation, and the competitive landscape. The research report has made use of graphics, tables and charts to present historical data and forecast figures. In addition, recommendations and inputs have also been listed in the report to guide the new players as well as the existing players operating in the market in designing their business policies and strategies.
Atopic dermatitis is a kind of skin disease or disorder in which the skin of a person becomes very itchy, inflamed, and dry. Scratching further results in scaling, weeping, crusting, redness, and swelling. This condition is very common in infants and can also affect adults. This condition may be inherited or it can be genetically determined. People living in severe dry climatic conditions are prone to be affected with the condition of atopic dermatitis.
The global atopic dermatitis treatment market is expected to witness high growth in the forecast period, owing to the increasing number of products on the market. The expected product launch of dupilumab, a product developed by Regeneron Pharmaceuticals, Inc. and Sanofi for treating the atopic dermatitis condition is projected to boost the demand for the atopic dermatitis treatment market across the globe. On the other hand, numerous side effects linked with products for atopic dermatitis treatment are projected to curb the growth of this market in the coming years.
Geographically, the global market for atopic dermatitis treatment has been segmented into Asia Pacific, North America, Europe, and Rest of the World. The research report has included a detailed regional analysis on the basis of volume and revenue. In the recent three decades, patients affected with atopic dermatitis condition have substantially increased in numbers. As per the statistics provided by the National Eczema Association, in the U.S., atopic dermatitis affects between 10% and 20% of infants. In Asia Pacific, China and India are the two main regions accounting for the biggest share of atopic dermatitis cases globally.
Furthermore, the research report talks about the competitive landscape of the global atopic dermatitis treatment market including the company overview, contact information, inception details, financial overview, business strategies, mergers and acquisitions, and recent developments. Some of the prominent players operating in this market are Regeneron Pharmaceuticals, Inc., Anacor Pharmaceuticals Inc., Meda AB., and Astellas Pharma.
Request For Free Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2125
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453